Andrew Tutt
MBChB, PhD
Professor of Oncology
👥Biography 个人简介
Andrew Tutt is a leader in BRCA associated and triple negative breast cancer research. He was a principal investigator on OlympiA which established adjuvant olaparib for germline BRCA carriers. His work has defined the role of PARP inhibitors in early stage breast cancer. He directs the Breast Cancer Now Toby Robins Research Centre.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Andrew Tutt 的研究动态
Follow Andrew Tutt's research updates
留下邮箱，当我们发布与 Andrew Tutt（Institute of Cancer Research and Kings College London）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment